Emory University

Joanna A Pulit-Penaloza

Richard W Compans

Ioanna Skountzou

Brian Pollack

This disclosure relates to using EGFR pathway inhibitors in combination with compositions comprising an antigen to increase, elicit, or improve an antigen or vaccine-induced immune response. In certain embodiments, the EGFR pathway inhibitor is administered under conditions such that memory cells to the antigen are formed in a subject. In certain embodiments, the composition is a vaccine. In certain embodiments, the EGFR pathway inhibitor and vaccine are administered to the skin epidermis or dermis.

Growing community of inventors

Atlanta, GA, United States of America

Joanna A Pulit-Penaloza